A 41-year-old woman with a history of persistent asthma presents to the nurse practitioner with a chief complaint of an increase in exacerbations. Why would a long-acting beta agonist (LABA) NOT be prescribed as monotherapy for this patient?

LABAs improve lung function and quality of life.

LABAs are recommended at step 3 of the national guidelines for the management of asthma.

Studies have shown an increased risk of sudden death in patients treated with LABA monotherapy only.

LABAs are currently recommended for the management of asthma for rescue situations.